NCT02347865View on ClinicalTrials.gov

Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France

CompletedOBSERVATIONAL
Enrollment

777

Participants

Timeline

Start Date

June 16, 2015

Primary Completion Date

October 26, 2017

Study Completion Date

September 27, 2018

Conditions
Post Menopausal Osteoporosis
Interventions
DRUG

AMG 162 - Prolia

500 patients

DRUG

AMG 162 - Prolia

250 patients, one year later

Trial Locations (1)

92200

Amgen, Paris

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY